Abstract:Serum amyloid A (SAA) proteins are one of the most inducible acute-phase reactants and are precursors of secondary amyloidosis. In the mouse, SAA1 and SAA2 are induced in approximately equal quantities in response to amyloid induction models. These two isotypes differ in only 9 of 103 amino acid residues; however, only SAA2 is selectively deposited into amyloid fibrils. SAA expression in the CE/J mouse species is an exception in that gene duplication did not occur and the CE/J variant is a hybrid molecule sharing features of SAA1 and SAA2. However, even though it is more closely related to SAA2 it is not deposited as amyloid fibrils. We have developed an adenoviral vector system to overexpress SAA proteins in cell culture to determine the ability of these proteins to form amyloid fibrils, and to study the structural features in relation to amyloid formation. Both the SAA2 and CE/J SAA proteins were synthesized in large quantities and purified to homogeneity. Electron microscopic analysis of the SAA proteins revealed that the SAA2 protein was capable of forming amyloid fibrils, whereas the CE/J SAA was incapable. Radiolabelled SAAs were associated with normal or acute-phase high-density lipoproteins (HDLs); we examined them for their clearance from the circulation. In normal mice, SAA2 had a half-life of 70 min and CE/J SAA had a half-life of 120 min; however, in amyloid mice 50% of the SAA2 cleared in 55 min, compared with 135 min for the CE/J protein. When the SAA proteins were associated with acute-phase HDLs, SAA2 clearance was decreased to 60 min in normal mice compared with 30 min in amyloidogenic mice. Both normal and acute-phase HDLs were capable of depositing SAA2 into preformed amyloid fibrils, whereas the CE/J protein did not become associated with amyloid fibrils. This established approach opens the doors for large-scale SAA production and for the examination of specific amino acids involved in the fibrillogenic capability of the SAA2 molecule in vitro and in vivo.

In vitro and ex vivo expression of serum amyloid A3 in mouse lung epithelia

An Essential Role for Stat3 in Regulating Igg Immune Complex-Induced Pulmonary Inflammation

Elevated Expression of Serum Amyloid A 3 Protects Colon Epithelium Against Acute Injury Through TLR2-Dependent Induction of Neutrophil IL-22 Expression in a Mouse Model of Colitis

Deficiency of Acute-Phase Serum Amyloid A Exacerbates Sepsis-Induced Mortality and Lung Injury in Mice

Functional Analysis of SAA3 During Interaction Between Actinobacillus pleuropneumoniaeand Porcine Alveola Macrophages

Abstract 447: Deficiency Of Serum Amyloid A Exacerbates Sepsis-induced Acute Lung Injury In Mice

Serum Amyloid A Exhibits Ph Dependent Antibacterial Action and Contributes to Host Defense Against Staphylococcus Aureus Cutaneous Infection.

Adenoviral Expression of Murine Serum Amyloid A Proteins to Study Amyloid Fibrillogenesis

Study on the expression of serum amyloid protein A in vivo in patients with rheumatoid arthritis

Serum Amyloid A1 (SAA1) Revisited: Restricted Leukocyte-Activating Properties of Homogeneous SAA1

Serum amyloid A: an ozone‐induced circulating factor with potentially important functions in the lung‐brain axis

Emerging Functions of Serum Amyloid A in Inflammation

Acute phase reactant serum amyloid A in inflammation and other diseases.

Serum Amyloid A Aggravates Endotoxin-Induced Ocular Inflammation Through the Regulation of Retinal Microglial Activation

Serum amyloid A1 induced dysfunction of airway macrophages via CD36 pathway in allergic airway inflammation

Expression of Mouse Acute-Phase (saa1.1) and Constitutive (saa4) Serum Amyloid A Isotypes - Influence on Lipoprotein Profiles

Inflammation-Dependent Cerebral Deposition of Serum Amyloid A Protein in A Mouse Model of Amyloidosis

Serum amyloid A induces interleukin-33 expression through an IRF7-dependent pathway.

Serum amyloid A1: Structure, function and gene polymorphism

Serum amyloid protein A in inflammatory bowel disease: from bench to bedside